Annual EBITDA
$4.25B$411.00M-8.83%
Summary
- Current Value
- As of today, REGN annual EBITDA is $4.25B, down -8.83% on
- Historical Performance
- REGN annual EBITDA is down -25.87% over the past 3 years, up +11.36% over the past 5 years
- All-Time High Comparison
- REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on
- 3-Year Low Comparison
- REGN annual EBITDA is at its 3-year low
- Sector Comparison
- REGN annual EBITDA is higher than 97.42% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.25B | -8.8% | -25.9% | +11.4% | +5558.3% | |
| Quarterly EBITDA | $868.00M | +18.8% | -21.3% | -26.4% | +2652.7% | |
| TTM EBITDA | $4.38B | -1.6% | -16.0% | +3.5% | +5132.3% | |
| Price | $714.89 | +35.5% | -4.1% | +42.6% | +1271.6% | |
| PE Ratio | 17.42 | +29.7% | -14.0% | +22.9% | – | |
| Annual Revenue | $14.34B | +1.0% | +17.8% | +68.8% | +3024.3% | |
| Annual EPS | $41.48 | +8.2% | +8.5% | +35.9% | +3392.2% | |
| $3.69B | -11.5% | -31.4% | +3.3% | +3888.6% | ||
| Annual Net Income | $4.50B | +2.1% | +3.8% | +28.2% | +4412.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.73B | N/A | -25.9% |
| 5Y | $9.23B | -54.0% | |
| All | $9.23B | -54.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.25B | at low | |
| 5Y | $3.81B | N/A | +11.4% |
| All | -$174.08M | +2539.0% |
EBITDA History
FAQ
What is the current annual EBITDA of REGN?
As of today, REGN annual EBITDA is $4.25B
What is 1-year change in REGN annual EBITDA?
REGN annual EBITDA is down -8.83% year-over-year
What is 3-year change in REGN annual EBITDA?
REGN annual EBITDA is down -25.87% over the past 3 years
How far is REGN annual EBITDA from its all-time high?
REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on December 31, 2021
How does REGN annual EBITDA rank versus sector peers?
REGN annual EBITDA is higher than 97.42% of companies in Healthcare sector
When is REGN next annual earnings release?
As of today, the next annual earnings release for REGN has not been scheduled
Quarterly EBITDA
$868.00M$175.60M-16.83%
Summary
- Current Value
- As of today, REGN quarterly EBITDA is $868.00M, down -16.83% on
- Historical Performance
- REGN quarterly EBITDA is up +18.76% year-over-year, down -21.26% over the past 3 years
- All-Time High Comparison
- REGN quarterly EBITDA is currently -74.61% below its historical high of $3.42B set on
- 3-Year Low Comparison
- REGN quarterly EBITDA is +18.76% above its 3-year low of $730.90M reached on
- Sector Comparison
- REGN quarterly EBITDA is higher than 96.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $868.00M | -16.8% | +18.8% | -21.3% | -26.4% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| TTM EBITDA | $4.38B | +3.2% | -1.6% | -16.0% | +3.5% | |
| Price | $714.89 | -8.2% | +35.5% | -4.1% | +42.6% | |
| PE Ratio | 17.42 | -7.0% | +29.7% | -14.0% | +22.9% | |
| Quarterly Revenue | $3.61B | -7.2% | +19.0% | +14.0% | +42.6% | |
| Quarterly EPS | $6.75 | -14.1% | -7.2% | -5.9% | -33.1% | |
| $744.80M | -17.1% | +23.3% | -25.7% | -33.1% | ||
| Quarterly Net Income | $727.20M | -13.9% | -10.1% | -11.1% | -34.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.25B | -30.4% | |
| 3Y | $1.36B | -36.0% | |
| 5Y | $3.42B | -74.6% | |
| All | $3.42B | -74.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $730.90M | N/A | +18.8% |
| 3Y | $730.90M | +18.8% | |
| 5Y | $730.90M | +18.8% | |
| All | -$52.42M | +1756.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of REGN?
As of today, REGN quarterly EBITDA is $868.00M
What is REGN quarterly EBITDA most recent change?
REGN quarterly EBITDA was down -16.83% on March 31, 2026
What is 1-year change in REGN quarterly EBITDA?
REGN quarterly EBITDA is up +18.76% year-over-year
How far is REGN quarterly EBITDA from its all-time high?
REGN quarterly EBITDA is currently -74.61% below its historical high of $3.42B set on June 30, 2021
How does REGN quarterly EBITDA rank versus sector peers?
REGN quarterly EBITDA is higher than 96.56% of companies in Healthcare sector
When is REGN next earnings release?
The next earnings release for REGN is on
TTM EBITDA
$4.38B$137.10M+3.23%
Summary
- Current Value
- As of today, REGN TTM EBITDA is $4.38B, up +3.23% on
- Historical Performance
- REGN TTM EBITDA is down -1.63% year-over-year, down -15.96% over the past 3 years
- All-Time High Comparison
- REGN TTM EBITDA is currently -53.44% below its historical high of $9.41B set on
- 3-Year Low Comparison
- REGN TTM EBITDA is +3.23% above its 3-year low of $4.25B reached on
- Sector Comparison
- REGN TTM EBITDA is higher than 97.30% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.38B | +3.2% | -1.6% | -16.0% | +3.5% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| Quarterly EBITDA | $868.00M | -16.8% | +18.8% | -21.3% | -26.4% | |
| Price | $714.89 | -8.2% | +35.5% | -4.1% | +42.6% | |
| PE Ratio | 17.42 | -7.0% | +29.7% | -14.0% | +22.9% | |
| TTM Revenue | $14.92B | +4.0% | +5.9% | +20.6% | +62.2% | |
| TTM EPS | $41.04 | -1.3% | +4.5% | +11.5% | +16.1% | |
| $3.84B | +3.8% | -3.0% | -20.8% | -3.7% | ||
| TTM Net Income | $4.42B | -1.8% | -1.7% | +5.8% | +10.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.47B | -1.9% | |
| 3Y | $5.22B | N/A | -16.0% |
| 5Y | $9.41B | -53.4% | |
| All | $9.41B | -53.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.25B | +3.2% | |
| 3Y | $4.25B | +3.2% | |
| 5Y | $4.24B | N/A | +3.5% |
| All | -$174.08M | +2617.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of REGN?
As of today, REGN TTM EBITDA is $4.38B
What is REGN TTM EBITDA most recent change?
REGN TTM EBITDA was up +3.23% on March 31, 2026
What is 1-year change in REGN TTM EBITDA?
REGN TTM EBITDA is down -1.63% year-over-year
How far is REGN TTM EBITDA from its all-time high?
REGN TTM EBITDA is currently -53.44% below its historical high of $9.41B set on March 31, 2022
How does REGN TTM EBITDA rank versus sector peers?
REGN TTM EBITDA is higher than 97.30% of companies in Healthcare sector
When is REGN next earnings release?
The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- REGN Official Website www.regeneron.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm
- REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
- REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn